Cancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.

by Jon Kelvey

For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.

by Cheryl Platzman Weinstock

Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.

by Jen Tota McGivney

Responding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones.

by Marci A. Landsmann

People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.

by William G. Nelson, MD, PhD

Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.

by Anna Azvolinsky

A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.

by Marci A. Landsmann

The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.

by Anna Azvolinsky

Cancer patients in the U.S. are feeling impacts from the new coronavirus.

by Kate Yandell

Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

by Ashley P. Taylor